Nefopam
- Generic Name
- Nefopam
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C17H19NO
- CAS Number
- 13669-70-0
- Unique Ingredient Identifier
- 4UP8060B7J
- Background
Nefopam is under investigation for the prevention of Cholecystitis and Post Anaesthetic Shivering. Nefopam has been investigated for the prevention of Kidney Transplantation.
- Indication
用于术后镇痛、癌痛、急性外伤痛。亦可用于急性胃炎、胆道蛔虫症、输尿管结石等内脏平滑肌收缩绞痛；局部麻醉、针麻等麻醉辅助用药。
- Associated Conditions
- Pain
- Associated Therapies
- -
The Preemptive Analgesic Efficacy of Nefopam
- First Posted Date
- 2015-09-28
- Last Posted Date
- 2016-04-06
- Lead Sponsor
- Seoul National University Bundang Hospital
- Target Recruit Count
- 94
- Registration Number
- NCT02561468
- Locations
- 🇰🇷
Seoul National University Bundang Hospital, Seongnam, Gyeonggi, Korea, Republic of
Effect of Intraoperative Nefopam on Acute Pain After Remifentanil Based Anesthesia
- First Posted Date
- 2015-07-09
- Last Posted Date
- 2015-09-02
- Lead Sponsor
- Hallym University Kangnam Sacred Heart Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT02493231
- Locations
- 🇰🇷
Hallym University Kangnam Sacred Heart Hospita, Seoul, Korea, Republic of
Nefopam vs Tramadol in the Prevention of Post Anaesthetic Shivering
- First Posted Date
- 2015-05-12
- Last Posted Date
- 2018-07-17
- Lead Sponsor
- Lagos State Health Service Commission
- Target Recruit Count
- 130
- Registration Number
- NCT02441673
Non-opioid Analgesic Combination With Morphine for Postoperative Analgesia.
- Conditions
- Interventions
- First Posted Date
- 2013-06-20
- Last Posted Date
- 2018-02-06
- Lead Sponsor
- Rennes University Hospital
- Target Recruit Count
- 223
- Registration Number
- NCT01882530
- Locations
- 🇫🇷
Marcel Chauvin, Boulogne, France
🇫🇷Xavier Capdevila, Montpellier, France
🇫🇷Hawa Keita-Meyer, Colombes, France
The Analgesic Effect of Nefopam on the Fentanyl Based PCA (Patient-controlled Analgesia) After Lumbar Spinal Surgery
- Conditions
- Interventions
- First Posted Date
- 2013-03-08
- Last Posted Date
- 2014-02-19
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 54
- Registration Number
- NCT01808014
- Locations
- 🇰🇷
Severance Hospital, Seoul, Korea, Republic of
Effect of Nefopam on Remifentanil Induced Postoperative Hyperalgesia
- Conditions
- Interventions
- First Posted Date
- 2012-11-26
- Last Posted Date
- 2014-02-19
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 25
- Registration Number
- NCT01732666
- Locations
- 🇰🇷
Severance hospital, Seoul, Korea, Republic of
Analgesic Efficacy of Nefopam in Patients Undergoing Kidney Transplantation
- Conditions
- Interventions
- First Posted Date
- 2012-06-19
- Last Posted Date
- 2013-08-20
- Lead Sponsor
- Severance Hospital
- Target Recruit Count
- 98
- Registration Number
- NCT01622881
- Locations
- 🇰🇷
Department of Anesthesiology and Pain Medicine and Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul, Korea, Republic of
Non Opioid Treatment for Experimental Dyspnea
- First Posted Date
- 2012-04-13
- Last Posted Date
- 2012-12-11
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 15
- Registration Number
- NCT01577407
- Locations
- 🇫🇷
Pitié salpetriere Hospital, Paris, France
Effect of Nefopam on Acute Postoperative Pain in Patients Undergoing Orthognathic Surgery
- Conditions
- First Posted Date
- 2011-10-27
- Last Posted Date
- 2021-02-04
- Lead Sponsor
- The Catholic University of Korea
- Target Recruit Count
- 40
- Registration Number
- NCT01461031
- Locations
- 🇰🇷
Seoul St.Mary's Hospital, Seoul, Seocho-gu, Korea, Republic of
Effects of Nefopam on Hyperalgesia After Cardiac Surgery
- Conditions
- Interventions
- First Posted Date
- 2006-12-19
- Last Posted Date
- 2010-05-28
- Lead Sponsor
- University Hospital, Bordeaux
- Target Recruit Count
- 90
- Registration Number
- NCT00413257
- Locations
- 🇫🇷
Département d'Anesthésie-Réanimation II - Hôpital cardiologique - Groupe Hospitalier Sud, CHU de Bordeaux - 4, Av de Magellan, Pessac, France
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.